HeartSciences Inc (HSCS)

Currency in USD
1.8100
-0.2200(-10.84%)
Closed·
1.9300+0.1200(+6.63%)
·
Unusual Post-Market activity
HSCS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.77002.0500
52 wk Range
1.63005.2500
Key Statistics
Prev. Close
2.03
Open
1.96
Day's Range
1.77-2.05
52 wk Range
1.63-5.25
Volume
174.63K
Average Volume (3m)
163.76K
1-Year Change
-23.3051%
Book Value / Share
-0.52
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HSCS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
12.0000
Upside
+562.98%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

HeartSciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 12.0000
(+562.98% Upside)

Earnings

Latest Release
Sep 16, 2026
EPS / Forecast
-0.86 / -0.70
Revenue / Forecast
2.1K / --
EPS Revisions
Last 90 days

HSCS Income Statement

Compare HSCS to Peers and Sector

Metrics to compare
HSCS
Peers
Sector
Relationship
P/E Ratio
−0.8x2.8x−0.2x
PEG Ratio
−0.01−0.020.00
Price/Book
−4.3x2.0x2.6x
Price / LTM Sales
1,922.6x2.2x2.6x
Upside (Analyst Target)
-61.8%76.9%
Fair Value Upside
Unlock24.4%14.9%Unlock

HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
92.18K1.92%166.84K
Other Institutional Investors
1.02M21.28%1.85M
Public Companies & Retail Investors
3.69M76.80%6.67M
Total
4.8M100.00%8.69M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Digital Currency Group Inc.8.57%411,522745
North Rock Digital, LP3.68%176,461319

People Also Watch

3.700
TOYO
-4.88%
640.53
CVCO
-1.46%
0.2296
INLF
-18.29%
4.75
CDNL
-8.30%
46.56
CNMD
+0.39%

FAQ

What Is the HeartSciences (HSCS) Stock Price Today?

The HeartSciences stock price today is 1.8100 USD.

What Stock Exchange Does HeartSciences Trade On?

HeartSciences is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for HeartSciences?

The stock symbol for HeartSciences is "HSCS."

What Is the HeartSciences Market Cap?

As of today, HeartSciences market cap is 9.7400M USD.

What Is HeartSciences's Earnings Per Share (TTM)?

The HeartSciences EPS (TTM) is -3.19.

When Is the Next HeartSciences Earnings Date?

HeartSciences will release its next earnings report on Dec 10, 2026.

From a Technical Analysis Perspective, Is HSCS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has HeartSciences Stock Split?

HeartSciences has split 1 times.

How Many Employees Does HeartSciences Have?

HeartSciences has 14 employees.

What is the current trading status of HeartSciences (HSCS)?

As of Nov 21, 2026, HeartSciences (HSCS) is trading at a price of 1.8100 USD, with a previous close of 2.0300 USD. The stock has fluctuated within a day range of 1.7700 USD to 2.0500 USD, while its 52-week range spans from 1.6300 USD to 5.2500 USD.

What Is HeartSciences (HSCS) Price Target According to Analysts?

The average 12-month price target for HeartSciences is 12.0000 USD, with a high estimate of 12 USD and a low estimate of 12 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +562.98% Upside potential.

What Is the HSCS Premarket Price?

HSCS's last pre-market stock price is 2.0100 USD. The pre-market share volume is 15,860.0000, and the stock has decreased by -0.0200, or -0.9900%.

What Is the HSCS After Hours Price?

HSCS's last after hours stock price is 1.9300 USD, the stock has decreased by 0.1200, or 6.6300%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.